|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CARRINGTON LABORATORIES INC /TX/, 10-Q, EX-10.2, 2000-11-14 |
Next: HUNTINGDON LIFE SCIENCES GROUP PLC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted
from (1) Statements of Balance Sheets, (2) Statements of
Operations and (3) Statements of Cash Flows, and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 2,240
<SECURITIES> 0
<RECEIVABLES> 2,348
<ALLOWANCES> 85
<INVENTORY> 4,702
<CURRENT-ASSETS> 9,633
<PP&E> 18,723
<DEPRECIATION> 8,177
<TOTAL-ASSETS> 20,579
<CURRENT-LIABILITIES> 3,133
<BONDS> 0
0
0
<COMMON> 96
<OTHER-SE> 17,350
<TOTAL-LIABILITY-AND-EQUITY> 20,579
<SALES> 17,586
<TOTAL-REVENUES> 17,713
<CGS> 9,481
<TOTAL-COSTS> 19,925
<OTHER-EXPENSES> 223
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (2,435)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,435)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,435)
<EPS-BASIC> (0.26)
<EPS-DILUTED> (0.26)
</TABLE>
|
|